#researchupdates — Public Fediverse posts

· New preprint links #LongCOVID symptom severity with higher DNA levels of the herpesvirus HHV6
[https://www.medrxiv.org/content/10.64898/2026.05.19.26353495v1.full-text]
· Svenska Covidföreningen published resource, “Designing Studies for Patients with #PEM", to improve research methods into #ME & Long COVID
[https://covidforeningen.se/wp-content/uploads/designing-studies-for-patients-with-pem-2.pdf]
· University of California, San Francisco actively recruiting for observational study on myalgic encephalomyelitis
[https://clinicaltrials.gov/study/NCT07227441]

https://thesicktimes.org/2026/05/26/research-updates-may-26/

#ResearchUpdates #TheSickTimes

· New preprint links #LongCOVID symptom severity with higher DNA levels of the herpesvirus HHV6
[https://www.medrxiv.org/content/10.64898/2026.05.19.26353495v1.full-text]
· Svenska Covidföreningen published resource, “Designing Studies for Patients with #PEM", to improve research methods into #ME & Long COVID
[https://covidforeningen.se/wp-content/uploads/designing-studies-for-patients-with-pem-2.pdf]
· University of California, San Francisco actively recruiting for observational study on myalgic encephalomyelitis
[https://clinicaltrials.gov/study/NCT07227441]

https://thesicktimes.org/2026/05/26/research-updates-may-26/

#ResearchUpdates #TheSickTimes

· New preprint links #LongCOVID symptom severity with higher DNA levels of the herpesvirus HHV6
[https://www.medrxiv.org/content/10.64898/2026.05.19.26353495v1.full-text]
· Svenska Covidföreningen published resource, “Designing Studies for Patients with #PEM", to improve research methods into #ME & Long COVID
[https://covidforeningen.se/wp-content/uploads/designing-studies-for-patients-with-pem-2.pdf]
· University of California, San Francisco actively recruiting for observational study on myalgic encephalomyelitis
[https://clinicaltrials.gov/study/NCT07227441]

https://thesicktimes.org/2026/05/26/research-updates-may-26/

#ResearchUpdates #TheSickTimes

· New preprint links #LongCOVID symptom severity with higher DNA levels of the herpesvirus HHV6
[https://www.medrxiv.org/content/10.64898/2026.05.19.26353495v1.full-text]
· Svenska Covidföreningen published resource, “Designing Studies for Patients with #PEM", to improve research methods into #ME & Long COVID
[https://covidforeningen.se/wp-content/uploads/designing-studies-for-patients-with-pem-2.pdf]
· University of California, San Francisco actively recruiting for observational study on myalgic encephalomyelitis
[https://clinicaltrials.gov/study/NCT07227441]

https://thesicktimes.org/2026/05/26/research-updates-may-26/

#ResearchUpdates #TheSickTimes

· New preprint links #LongCOVID symptom severity with higher DNA levels of the herpesvirus HHV6
[https://www.medrxiv.org/content/10.64898/2026.05.19.26353495v1.full-text]
· Svenska Covidföreningen published resource, “Designing Studies for Patients with #PEM", to improve research methods into #ME & Long COVID
[https://covidforeningen.se/wp-content/uploads/designing-studies-for-patients-with-pem-2.pdf]
· University of California, San Francisco actively recruiting for observational study on myalgic encephalomyelitis
[https://clinicaltrials.gov/study/NCT07227441]

https://thesicktimes.org/2026/05/26/research-updates-may-26/

#ResearchUpdates #TheSickTimes

· The antiviral ensitrelvir was found to prevent* #COVID19 in people exposed to #CovidPositive individuals
[https://www.nejm.org/doi/10.1056/NEJMoa2509306]
· The U.K. government recently announced £4.75 million ($6.4 million USD) in funding for a genomics study of #ME
[https://www.gov.uk/government/news/thousands-of-mecfs-patients-to-benefit-from-first-genomics-study]
· A new phase 2 trial studying a compound for #LongCOVID related #tinnitus was recently announced
[https://clinicaltrials.gov/study/NCT07567274]

https://thesicktimes.org/2026/05/19/research-updates-may-19/

#ResearchUpdates #TheSickTimes

*hmm

· New study linked ongoing endothelial dysfunction in people with #LongCOVID with neuropsychiatric symptoms
[https://www.sciencedirect.com/science/article/pii/S2666354626000803?via%3Dihub#sec11]
· Small observational study from Jamaica found nearly half of pediatric participants met the diagnostic criteria for Long COVID
[https://journals.lww.com/pidj/fulltext/9900/long_covid_19_in_hospitalized_and_ambulatory.1720.aspx]
· Long COVID clinical trial investigating the cancer drug (sirolimus) rapamycin was recently updated to have an open label extension
[https://www.als-mnd.org/support-for-pals-cals/research/open-label-extension/]

https://thesicktimes.org/2026/05/12/research-updates-may-12/

#ResearchUpdates #COVID

· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full]

https://thesicktimes.org/2026/05/05/research-updates-may-5/

#ResearchUpdates #COVID #PandemicIsNotOver

· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full]

https://thesicktimes.org/2026/05/05/research-updates-may-5/

#ResearchUpdates #COVID #PandemicIsNotOver

· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full]

https://thesicktimes.org/2026/05/05/research-updates-may-5/

#ResearchUpdates #COVID #PandemicIsNotOver

· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full]

https://thesicktimes.org/2026/05/05/research-updates-may-5/

#ResearchUpdates #COVID #PandemicIsNotOver

· A specific formula of probiotics was found to improve fatigue and other symptoms in people with #LongCOVID
[https://aga-fileuploader-bucket.s3.us-east-2.amazonaws.com/389%20Probiotics%20and%20Long%20COVID%20FNL.pdf]
· A new review on Long COVID concluded that addressing the heterogeneity of the disease is crucial for the future development of treatments
[https://www.nature.com/articles/s43856-025-01300-z]
· Another review in Frontiers evaluated PEM
[https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774310/full]

https://thesicktimes.org/2026/05/05/research-updates-may-5/

#ResearchUpdates #COVID #PandemicIsNotOver

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· Written memorials of over 500 people who had myalgic encephalomyelitis (#ME) were analyzed in a new study in PLoS One
[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343374]
· New study in Pediatric Research found microclots in the blood of children with #LongCOVID
[https://www.nature.com/articles/s41390-026-05024-1]
· A third cancer drug is being trialed for Long COVID
[https://clinicaltrials.gov/study/NCT07388550]

https://thesicktimes.org/2026/04/28/research-updates-april-28/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new RECOVER study found that #LongCOVID significantly impacts the development of children with the disease
[https://www.academicpedsjnl.net/article/S1876-2859(26)00096-3/fulltext]
· A recent preprint found that a nasal monoclonal antibody improved Long COVID cognitive dysfunction in mice
[https://www.biorxiv.org/content/10.64898/2026.04.07.716934v2]
· A phase four clinical trial in Toronto, Ontario, will evaluate stellate ganglion blocks (SGB) for Long COVID
[https://clinicaltrials.gov/study/NCT07468604?cond=Dysautonomia&aggFilters=status:not%20rec&viewType=Card&rank=3]

https://thesicktimes.org/2026/04/21/research-updates-april-21/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A new report found that #LongCOVID may cost OECD international economies over $135 billion per year over the next decade
· Long COVID is associated with an increased risk of cardiovascular disease, a new study in The Lancet found
· A small study identified persistent immune dysregulation and coagulation in people with post-vaccine syndrome (PVS) from COVID-19 vaccines

https://thesicktimes.org/2026/04/14/research-updates-april-14/

#ResearchUpdates #TheSickTimes

· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseases

https://thesicktimes.org/2026/04/07/research-updates-april-7/

#ResearchUpdates #COVID #PandemicIsNotOver

· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseases

https://thesicktimes.org/2026/04/07/research-updates-april-7/

#ResearchUpdates #COVID #PandemicIsNotOver

· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseases

https://thesicktimes.org/2026/04/07/research-updates-april-7/

#ResearchUpdates #COVID #PandemicIsNotOver

· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseases

https://thesicktimes.org/2026/04/07/research-updates-april-7/

#ResearchUpdates #COVID #PandemicIsNotOver

· A clinical trial for non-invasive vagal nerve stimulation failed in improving fatigue in #LongCOVID
· A new study in JACC Advances compared two common types of dysautonomia in Long COVID, as well as their overlap
· German health insurance companies will cover four off-label drugs for Long COVID and related diseases

https://thesicktimes.org/2026/04/07/research-updates-april-7/

#ResearchUpdates #COVID #PandemicIsNotOver

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· Heart failure drug Ivabradine didn't significantly improve symptoms for people with #LongCOVID & #POTS, say preliminary results RECOVER researchers shared at conference
· Another study has found that injecting autoantibodies from people with Long COVID into mice causes “pain-like behavior” in the animals
· Clinical trial testing fibrinolytic enzyme lumbrokinase now offering decentralized option, participants can participate from home

https://thesicktimes.org/2026/03/31/research-updates-march-31/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· More than 150,000 deaths from #COVID19 went uncounted in the U.S. in the first two years of the pandemic, a new study in Science Advances finds
· Swiss researchers have found up to 60% of healthcare workers in a medium-size cohort study may have at least one symptom of #LongCOVID
· Small clinical trial recruiting in Orange, CA, to test Percutaneous Electrical Nerve Field Stimulation in children with post-concussion syndrome and LC

https://thesicktimes.org/2026/03/24/research-updates-march-24/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· Two recent prevalence studies showed the impact of #LongCOVID on Americans
· A small study shared as a preprint in bioXriv found SARS-C0V-2 spike protein in the gut tissues of people with Long COVID
· Researcher Dianna Arnoux-Whiteman was awarded a $45,000 grant to survey the effects of Long COVID in the Blackfeet Nation

https://thesicktimes.org/2026/03/17/research-updates-march-17/

#ResearchUpdates #TheSickTimes

· A large retrospective cohort study found significant healthcare cost increases for #LongCOVID over five years
· A South Korean clinical trial evaluated metformin and ursodeoxycholic acid (UDCA) for Long COVID, but didn’t find either effective
· Two recent preprints share additional analysis from clinical trials seeking to address viral persistence

https://thesicktimes.org/2026/03/10/research-updates-march-10/

#ResearchUpdates #COVID

· Researchers identified high levels of cytokine interferon gamma (IFN-γ) as a potential biomarker for #LongCOVID
· Two new studies compare SARS-CoV-2’s long-term risks to those of the flu
· A small phase 1 clinical trial will test the safety of the cancer monoclonal antibody Pembrolizumab (Keytruda)

https://thesicktimes.org/2026/03/03/research-updates-march-3/

#ResearchUpdates #COVID

· SARS-CoV-2 reinfections significantly increase the risk of #LongCOVID in children, a new National Institutes of Health (NIH) RECOVER study found
· A large cohort study found further evidence that people with #HIV have a significantly increased risk of Long COVID following SARS-CoV-2 infection
· An in-depth whole genome sequencing study called Sequence #MECFS and Long COVID is seeking to raise £20 million ($23.6 million USD) in funding

https://thesicktimes.org/2026/02/24/research-updates-february-24/

#ResearchUpdates #TheSickTimes